Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apex Healthcare | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.51B | 19.6x | -0.25 | MYR 2.09 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.2% Upside | Upgrade to Pro+ | |
Duopharma Biotech | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 1.15B | 18.3x | 1 | MYR 1.20 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
Amway | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 943.57M | 9.8x | -0.64 | MYR 5.74 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Kotra Industries | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 585.84M | 14.6x | -0.54 | MYR 3.95 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.1% Upside | Upgrade to Pro+ | |
Pharmaniaga Bhd | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 317.07M | 2.5x | 0.01 | MYR 0.22 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
YSP Southeast Asia | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 306.39M | 11.5x | -0.4 | MYR 2.16 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhone Ma | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 137.16M | 11.6x | 6.64 | MYR 0.64 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.7% Upside | Upgrade to Pro+ | |
Bioalpha | Kuala Lumpur | Healthcare | Pharmaceuticals | MYR 56.26M | -1.1x | 0.21 | MYR 0.04 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |